This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Related articles  • Similar articles in JAMA  Topic Collections  • Cardiovascular System  • Cardiovascular Disease/ Myocardial Infarction  • Genetics  • Genetics, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

₂-Adrenergic Receptor Genotype and Survival After Acute Coronary Syndrome

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: The study by Dr Lanfear and colleagues¹ showed an apparent disconnect between the effects that ADRB2 and ADRB1 variants have on survival in patients receiving -blockers after an acute coronary syndrome. The homozygous composite genotypes comprising Arg-Arg16 /Gln-Gln 27 (46AA/79CC) and Gly-Gly16/Glu-Glu 27 (46GG/79GG) were associated with a higher and lower risk of death, respectively, amounting to a 14% difference in mortality rate over 3 years.

The acute fall in serum potassium level and diastolic blood pressure in response to ADRB2 stimulation by albuterol is significantly greater in patients with genotype 46AA/79CC compared with 46GG/79GG.² This suggests the possibility of a genetic susceptibility to the ADRB2-mediated adverse effects of raised levels of endogenous circulating epinephrine in the high-risk group when treated with -blockers.

The authors did not state which -blockers were used in the study. This is relevant because the more commonly used 1-selective blockers might . . . [Full Text of this Article]

Catherine M. Jackson, MD
Tayside Centre for General Practice

Brian J. Lipworth, MD
b.j.lipworth@dundee.ac.uk
Division of Medicine and Clinical Pharmacology
Ninewells Hospital and Medical School
Dundee, Scotland

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLES

{beta}2-Adrenergic Receptor Genotype and Survival Among Patients Receiving {beta}-Blocker Therapy After an Acute Coronary Syndrome
, , , , , and
JAMA. ;294():1526-1533.
FULL TEXT  

beta2-Adrenergic Receptor Genotype and Survival After Acute Coronary Syndrome
and
JAMA. ;295():756-757.
FULL TEXT  

beta2-Adrenergic Receptor Genotype and Survival After Acute Coronary Syndrome--Reply
, , and
JAMA. ;295():757-758.
FULL TEXT